Sascan Meditech, developed a unique device to detect oral cancers early

▴ Sascan Meditech, developed a unique device to detect oral cancers early
Sascan Meditech Pvt Ltd has developed a unique device called ‘OralScan’ which could detect oral cancers early

Sascan Meditech Pvt Ltd, a startup company, which incubated at Technology Business Incubator of Sree Chitra Tirunal Institute for Medical Sciences & Technology is launching OralScan which is a Make- in- India initiative with seed funding from the scheme National Initiative for Developing and Harnessing Innovations (NIDHI) of the Department of Science & Technology (DST).

Oral scan was designed and developed entirely in India. According to Dr Subhash Narayanan, CEO of Sascan, oral cancer is a growing concern in India with more than 80,000 fresh cases reported each year.

The disease has a high mortality rate because of the delay in detection. Current practice relies on oral examinations using a torch light to detect early stage cancers of the oral cavity.

Various studies have demonstrated that this screening technique is not very reliable and often oral potentially malignant lesions (OPMLs) go undetected in the early stages. Even experienced clinicians find it difficult to locate the optimal site for a biopsy based on conventional oral examination.

This leads to multiple biopsies, increased expenditure and false negative reports which can delay diagnosis and outcome.

It is in this context that the OralScan, a handheld imaging device developed by Sascan for screening, detection of OPMLs and biopsy guidance becomes relevant. A software assists the surgeon in taking biopsy from the most appropriate site which is likely to confirm the diagnosis of malignancy.

The device will be marketed at a price of Rs 5.9 Lakhs. This will be a one- time investment for hospitals and laboratories without any additional costs of consumables. OralScan has also undergone multicentric trials covering 6 hospitals across the country.

Sascan, has already obtained ISO 13485 certification Indian patent has been granted for the technology and US patent has been filed. OralScan has also undergone multicentric trials covering 6 hospitals across the country.

Tags : #SascanMeditech #LatestNewsonSascanMeditech28thOct #LatestNewsonOralCancers28thOct #LatestPharmaNews28thOct #India #SreeChitraTirunalInstituteforMedicalSciencesTechnology #MakeinIndia #DrSubhashNarayanan #OralCavity #MortalityRate #OralCancers

About the Author

Team Medicircle

Related Stories

Loading Please wait...

Trending Now

TeleSense Canada and PharmRight Announces Exclusive Canadian Partnership to offer Livi™ a Smart Medication Dispensing SolutionNovember 27, 2020
70% of India’s Active Caseload from Maharashtra, Kerala, Delhi, Rajasthan, Uttar Pradesh, Karnataka, West Bengal, and ChhattisgarhNovember 27, 2020
Apollo Hospitals, Bangalore has introduced Robotic Assisted Joint Replacement ProgramNovember 27, 2020
Gujarat: 5 patients die as fire breaks out in ICU of private Covid hospital in RajkotNovember 27, 2020
Astellas receives approval of EVRENZO in Japan for the treatment of anemia of chronic kidney diseaseNovember 27, 2020
PM Modi to embark on three city visit tomorrow to review COVID-19 vaccine developmentNovember 27, 2020
PostEra and NeuroLucent collaborate on identifying small-molecule therapeutics for Alzheimer's diseaseNovember 27, 2020
India's COVID-19 recovery rate reaches 93.65 Percent.November 27, 2020
Global guidelines on physical activity and sedentary behaviour November 27, 2020
Telangana: COVID-19 recovery rate slightly improves to 95.4%November 27, 2020
HopeQure receives HIPPA certification, expands its footprints in the US marketsNovember 27, 2020
A genomic analysis to determine an individual's response to COVID-19 : Veritas InternationalNovember 27, 2020
COVID-19 situation in state under control: Chhattisgarh Health MinisterNovember 27, 2020
Tripura: COVID-19 recovery rate improves to 96.69%November 27, 2020
MP reports 14,199 active COVID-19 casesNovember 27, 2020
Karnataka: Pandemic shows a decline with reduced positivity & fatality ratesNovember 27, 2020
Puducherry: Downward trend in Covid-19 continues with 16 new cases, the lowest in recent monthsNovember 27, 2020
Cancer may soon be treated with a new low-cost method using mitochondrial proteins called VDACNovember 27, 2020
Phase-3 trial of Bharat Biotech's Covaxin starts at Delhi AIIMS HospitalNovember 27, 2020
COVID-19 recovery rate remains at 90.93 per cent in GujaratNovember 27, 2020